Vitamin D levels for optimum bone health

Area of Science:

• Endocrinology
• Nutritional Science
• Public Health

Background:

• Traditional assessment of vitamin D deficiency relies on severe conditions like rickets and osteomalacia.
• This narrow focus leads to many clinically asymptomatic patients with vitamin D deficiency remaining undetected.
• Vitamin D deficiency is linked to secondary hyperparathyroidism, indicating a need for better diagnostic markers.

Purpose of the Study:

• To evaluate the normalization of intact parathyroid hormone (iPTH) as a surrogate marker for vitamin D nutrition adequacy.
• To identify a minimum vitamin D level required to maintain iPTH within a target range.
• To advocate for redefining optimal vitamin D levels based on iPTH normalization.

Main Methods:

• A descriptive study was conducted on 195 premenopausal Pakistani women.
• Levels of 25-hydroxy-cholecalciferol and intact parathyroid hormone (iPTH) were measured using standard laboratory techniques.

Main Results:

• The minimum level of vitamin D required to maintain iPTH below 53 pg/dL was determined to be 16 ng/ml.
• This finding was established with a 95 percent confidence interval of 13.8 to 18.2 ng/ml.
• The established normal range for vitamin D is currently 9-36 ng/ml, suggesting a potential need for revision.

Conclusions:

• Utilizing iPTH normalization as a criterion can detect clinically asymptomatic vitamin D deficiency.
• This method is simple, cost-effective, and offers potential skeletal and non-skeletal health benefits.
• International standardization and clinical adoption of this criterion are essential for redefining optimal vitamin D levels.